Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient

Medical Physics

Volumn 40, Issue 10, 2013, Pages

  Kletting, P ^a   Schimmel, S ^a   Kestler, H A ^a   Hanscheid H ^b   Luster, M ^a   Fernandez M ^b   Broer J H ^c   Nosske, D ^c   Lassmann, M ^b   Glatting, G ^d  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dosimetry; Molecular radiotherapy; Software; Targeted radionuclide therapy

Indexed keywords

ACTIVITY COEFFICIENTS; COMPUTER SOFTWARE; DOSIMETRY; ERRORS; INTEGRATION; MATLAB; RADIOTHERAPY;

ADJUSTABLE PARAMETERS; AKAIKE INFORMATION CRITERION; BAYESIAN INFORMATION; COEFFICIENT OF DETERMINATION; CORRECTED AKAIKE INFORMATION CRITERIONS; OBJECTIVE FUNCTIONS; SUMS OF EXPONENTIALS; TARGETED RADIONUCLIDE THERAPIES;

APPLICATION PROGRAMS;

GALLIUM 68;

ANALYTICAL ERROR; AREA UNDER THE CURVE; ARTICLE; BAYESIAN LEARNING; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSIMETRY; HUMAN; IMAGE QUALITY; INFORMATION PROCESSING; KERNEL METHOD; LEARNING ALGORITHM; MATHEMATICAL MODEL; MOLECULAR RADIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; QUANTITATIVE STUDY; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; STANDARD; THYROID CANCER; TIME; UNCERTAINTY; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; PROCEDURES;

RADIOTHERAPY, COMPUTER-ASSISTED; SOFTWARE; TIME FACTORS;

EID: 84885751261     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4820367     Document Type: Article

References (27)

1. M. Konijnenberg, "From imaging to dosimetry and biological effects," Q. J. Nucl. Med. Mol. Imaging 55, 44-56 (2011).
2. G. Glatting, M. Bardies and M. Lassmann, "Treatment planning in molecular radiotherapy," Z. Med. Phys. 23 (2013). [Epub ahead of print].
3. K. P. Burnham and D. R. Anderson, Model Selection and Multimodel Interference-A Practical Information-Theoretic Approach, 2nd ed. (Springer, New York, 2002).
4. R. F. Muzic, Jr. and B. T. Christian, "Evaluation of objective functions for estimation of kinetic parameters," Med. Phys. 33, 342-353 (2006).
5. P. L. Bonate, Pharmacokinetics Pharmacodynamics Modeling and Simulation, 2nd ed. (Springer, New York, 2011).
6. G. Glatting, P. Kletting, S. N. Reske, K. Hohl, and C. Ring, "Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test," Med. Phys. 34, 4285-4292 (2007).
7. E. M. Landaw and J. J. D. DiStefano, "Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations," Am. J. Physiol. 246, R665-677 (1984).
8. R. Wierts, C. D. de Pont, B. Brans, F. M. Mottaghy, and G. J. Kemerink, "Dosimetry in molecular nuclear therapy," Methods 55, 196-202 (2011).
9. G. Sgouros, E. Frey, R. Wahl, B. He, A. Prideaux, and R. Hobbs, "Three-dimensional imaging-based radiobiological dosimetry," Semin. Nucl. Med. 38, 321-334 (2008).
10. M. G. Stabin, R. B. Sparks, and E. Crowe, "OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine," J. Nucl. Med. 46, 1023-1027 (2005).
11. H. J. Motulsky and A. Christopoulos, Fitting Models to Biological Data using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting (Oxford University Press, New York 2004).
12. P. H. Barrett, B. M. Bell, C. Cobelli, H. Golde, A. Schumitzky, P. Vicini, and D. M. Foster, "SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies," Metabolism 47, 484-492 (1998).
13. P. Kletting, T. Kull, D. Bunjes, B. Mahren, M. Luster, S. N. Reske, and G. Glatting, "Radioimmunotherapy with anti-CD66 antibody: Improving the biodistribution using a physiologically based pharmacokinetic model," J. Nucl. Med. 51, 484-491 (2010).
14. P. Kletting, B. Muller, B. Erentok, J. Schmaljohann, F. F. Behrendt, S. N. Reske, F. M. Mottaghy, and G. Glatting, "Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy," Med. Phys. 39, 5708-5717 (2012).
15. M. Lassmann, H. Hanscheid, D. Gassen, J. Biko, V. Meineke, C. Reiners, and H. Scherthan, "In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer," J. Nucl. Med. 51, 1318-1325 (2010).
16. B. M. Bell, J. V. Burke, and A. Schumitzky, "A relative weighting method for estimating parameters and variances in multiple data sets," Comput. Stat. Data Anal. 22, 119-135 (1996).
17. J. A. Siegel, S. R. Thomas, J. B. Stubbs, M. G. Stabin, M. T. Hays, K. F. Koral, J. S. Robertson, R. W. Howell, B. W. Wessels, D. R. Fisher, D. A. Weber, and A. B. Brill, "MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates," J. Nucl. Med. 40, 37S-61S (1999).
18. H. Hänscheid, C. Canzi, W. Eschner, G. Flux, M. Luster, L. Strigari, and M. Lassmann, "EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II: Radioiodine dosimetry prior to radioiodine therapy of benign thyroid diseases," Eur. J. Nucl. Med. Mol. Imaging 40(7), 1126-1134 (2013).
19. S. Schimmel, Entwicklung des Moduls "Modellierung und Kurvenanpassung," für die Dosimetriesoftware NUKDOS, 2012.
20. E. M. Landaw and J. J. DiStefano III, "Multiexponential, multicompart-mental, and noncompartmental modeling. II. Data analysis and statistical considerations," Am. J. Physiol. 246, R665-R677 (1984).
21. P. Kletting and G. Glatting, "Model selection and inference in pharmacokinetics: The corrected Akaike information criterion and the F-test," Z. Med. Phys. 19, 200-206 (2009).
22. A. Divoli, A. Spinelli, S. J. Chittenden, D. P. Dearnaley, and G. Flux, "Whole-body dosimetry for targeted radionuclide therapy using spectral analysis," Cancer Biother. Radiopharm. 20(1), 66-71 (2005).
23. M. G. Cox, "Modelling clinical decay data using exponential functions," in Approximation Algorithms for Complex Systems, edited by E. H. Georgoulis, A. Iske, and J. Levesley (Springer, Berlin Heidelberg, 2011), Vol. 3, pp. 183-203.
24. M. Lassmann, C. Chiesa, G. Flux, and M. Bardiès, "EANM Dosimetry Committee guidance document: Good practice of clinical dosimetry reporting," Eur. J. Nucl. Med. Mol. Imaging 38, 192-200 (2011).
25. M. G. Stabin, "Uncertainties in internal dose calculations for radiopharma-ceuticals," J. Nucl. Med. 49, 853-860 (2008).
26. S. E. Strand, P. Zanzonico, and T. K. Johnson, "Pharmacokinetic modeling," Med. Phys. 20, 515-527 (1993).
27. M. E. Wastney, B. H. Patterson, O. A. Linares, and P. C. Greif, Investigating Biological Systems Using Modeling (Academic, 1998).